Bone Biologics Corporation
General ticker "BBLG" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $5.1M (TTM average)
Bone Biologics Corporation does not follow the US Stock Market performance with the rate: -25.0%.
Estimated limits based on current volatility of 5.1%: low 1.57$, high 1.74$
Factors to consider:
- Total employees count: 3 as of 2015
- Top business risk factors: Going concern, Limited operating history, Insufficient funding, Cybersecurity threats, Regulatory and compliance
- Current price 52.3% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.71$, 11.88$]
- 2025-12-31 to 2026-12-31 estimated range: [2.33$, 7.87$]
Financial Metrics affecting the BBLG estimates:
- Positive: with PPE of -0.2 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -46.57 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Negative: negative Industry operating income (median)
- Negative: -0.75 < Inventory ratio change, % of 0
Short-term BBLG quotes
Long-term BBLG plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $3.67MM | $9.43MM | $4.22MM |
| Operating Income | $-3.67MM | $-9.43MM | $-4.22MM |
| Non-Operating Income | $2.18MM | $0.48MM | $0.11MM |
| R&D Expense | $1.58MM | $6.91MM | $2.13MM |
| Income(Loss) | $-1.48MM | $-8.95MM | $-4.11MM |
| Profit(Loss)* | $-1.48MM | $-8.95MM | $-4.11MM |
| Stockholders Equity | $5.95MM | $2.91MM | $3.48MM |
| Assets | $8.50MM | $3.74MM | $3.86MM |
| Operating Cash Flow | $-3.57MM | $-9.56MM | $-4.12MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $4.43MM | $5.04MM | $4.42MM |
| Earnings Per Share** | $-31.19 | $-34.01 | $-2.71 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.